PPAR Gamma and Hepatic Stellate Cells
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Activation of Hepatic stellate cells (HSC) in fibrogenesis involves distinct morphological and biochemical changes. This activation requires the coordinated changes in activity of several transcription factors. Peroxisome proliferator-activated receptor gamma (PPAR gamma) is one such factor whose activity is decreased in activated HSC. PPAR gamma ligands suppress several markers of HSC activation such as expression of collagen and alpha smooth muscle actin (alpha-SMA), cell proliferation and migration. Expression of PPAR gamma, per se, also inhibits HSC activation. These findings support the role of PPAR gamma in reversion of activated HSC toward their quiescent state.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PPARs include three distinct isoforms: PPAR-α (NR1C1), which is highly expressed in oxidative tissues such as in liver.PPAR-δ (NR1C2), which is expressed in inflammatory cells and different liver cells including hepatocytes, HSCs and Kupffer cells.And PPAR-γ (NR1C3), traded as the most promising PPAR target involved in HSC activation.[104]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [104]
Experimental — accuracy not yet measuredIn the citing paper
“PPAR-γ represents the most promising PPAR target in HSCs, since it is a key factor in HSC activation and phenotype alteration.[104]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chawla, A., Barak, Y., Nagy, L., Liao, D., Tontonoz, P., & Evans, R. M. (2001) · Nature Medicine · doi:10.1038/83336 · Cited by 1,069 · cited 1×
“asp BioMedcentral and TZD) rendered some of known biological effects via PPAR gamma independent manner [6].”
BackgroundTHE JOURNAL OF BIOLOGICAL CHEMISTRY.
(1905) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1905.02510220045008 · Cited by 596
Peroxisome proliferator-activated receptors and hepatic stellate cell activation
Miyahara, T., Schrum, L., Rippe, R., Xiong, S., Yee, H. F., Motomura, K., Anania, F. A., Willson, T. M., & Tsukamoto, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006577200 · Cited by 473 · cited 5×
“al demonstrated that 15dPGJ2 and BRL49653 (rosiglitazone) suppressed DNA synthesis by 40–50% in cultured activated HSC [4].”
BackgroundResultSelf-citationGalli, A., Crabb, D. W., Ceni, E., Salzano, R., Mello, T., Svegliati–Baroni, G., Ridolfi, F., Trozzi, L., Surrenti, C., & Casini, A. (2002) · Gastroenterology · doi:10.1053/gast.2002.33666 · Cited by 440 · cited 1×
“Finally, the treatment with TZD was shown to ameliorate liver fibrosis in both toxic and cholestatic models [5].”
BackgroundMarra, F., Efsen, E., Romanelli, R. G., Caligiuri, A., Pastacaldi, S., Batignani, G., Bonacchi, A., Caporale, R., Laffi, G., Pinzani, M., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.9365 · Cited by 409
Galli, A., Crabb, D., Price, D., Ceni, E., Salzano, R., Surrenti, C., & Casini, A. (2000) · Hepatology · doi:10.1002/hep.510310117 · Cited by 197 · cited 3×
“also independently showed that PDGF stimulated proliferation of human HSC was inhibited by 15dPGJ2, ciglitazone and troglitazone [2,3].”
BackgroundMethodDiminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis
Ohata, M., Lin, M., Satre, M., & Tsukamoto, H. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.272.3.g589 · Cited by 116
Self-citationOhata, H., Ujike, Y., & Momose, K. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.272.6.c1980 · Cited by 70
Research works printed but not linked: 1
- Hazra S, She H, Xiong S, Rippe RA, Tangkjvanich P, Yee H, Tsukamoto H: PPAR gamma regulation of Hepatic Stellate Cells abstract. Hepatology. 2001, 34: 444A-
Cited by
Tsukada, S., Parsons, C. J., & Rippe, R. A. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.014 · Cited by 357
Self-citationCurrent status of novel antifibrotic therapies in patients with chronic liver disease
Cohen-Naftaly, M., & Friedman, S. L. (2011) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x11413002 · Cited by 186
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158
“More-over, certain patterns of DNA methylation at fibrosis-related genes, such as those encoding TGFβ1, COL1A1, PDGFα, peroxisome pro-liferator – activated receptor alpha (PPARα), and peroxisome proliferator – activated receptor delta (PPARδ), can not only distinguish between patients with mild versus advanced MASLD b…”
BackgroundInfluentialHepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis
Hu, M., Wang, Y., Liu, Z., Yu, Z., Guan, K., Liu, M., Wang, M., Tan, J., & Huang, L. (2021) · Nature Nanotechnology · doi:10.1038/s41565-020-00836-6 · Cited by 136
Gressner, O. A., Lahme, B., Rehbein, K., Siluschek, M., Weiskirchen, R., & Gressner, A. M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.029 · Cited by 133
Metadata
- Authors
- Hazra, S., Miyahara, T., Rippe, R. A., & Tsukamoto, H.
- Affiliations
- University of Southern California (US)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Hazra, Saswati
- ORCID
- Tsukamoto, Hidekazu
- Venue
- Comparative Hepatology
- Published
- 2004-01-14
- Volume
- 3
- Issue
- S1
- Pages
- S7-S7
- ISSN
- 1476-5926 (ISSN-L)
- PMC
- PMC2410230
- OpenAlex
- W2159202892
- Cited by
- 66
- References
- 8
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 7 · 2020: 4 · 2019: 5 · 2018: 1 · 2017: 3 · 2016: 3 · 2014: 1 · 2013: 4 · 2012: 2
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Comparative Hepatology (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- PPARγ, hepatic stellate cells, hepatic stellate cell activation, liver fibrosis, transcription factors, collagen expression, alpha-smooth muscle actin, cell proliferation, cell migration, PPARγ ligands, quiescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PPAR Gamma and Hepatic Stellate Cells. https://app.cochat.ai/papers/10.1186/1476-5926-2-s1-s7
- The paper
- Hazra, S., Miyahara, T., Rippe, R. A., & Tsukamoto, H. (2004). PPAR Gamma and Hepatic Stellate Cells. Comparative Hepatology. https://doi.org/10.1186/1476-5926-2-s1-s7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.